Terms: = Ovarian cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
76 results:
1. Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study.
Savoye I; Silversmit G; Bourgeois J; De Gendt C; Leroy R; Peacock HM; Stordeur S; de Sutter P; Goffin F; Luyckx M; Orye G; Van Dam P; Van Gorp T; Verleye L
Eur J Cancer; 2023 Dec; 195():113402. PubMed ID: 37922631
[TBL] [Abstract] [Full Text] [Related]
2. treatment of Recurrent Low-grade Serous ovarian cancer With MEK Inhibitors: A Systematic Review.
Kulkarni A; Cooke C; Fazelzad R; Fung-Kee-Fung M; May T; Zigras T
Am J Clin Oncol; 2024 Jan; 47(1):11-16. PubMed ID: 37823720
[TBL] [Abstract] [Full Text] [Related]
3. Bevacizumab treatment for Low-Grade Serous ovarian cancer: A Systematic Review.
Lazurko C; Linder R; Pulman K; Lennox G; Feigenberg T; Fazelzad R; May T; Zigras T
Curr Oncol; 2023 Sep; 30(9):8159-8171. PubMed ID: 37754507
[TBL] [Abstract] [Full Text] [Related]
4. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
Thao V; Moriarty JP; Stewart EA; Borah BJ
J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
[TBL] [Abstract] [Full Text] [Related]
5. A retrospective analysis of secondary cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in patients with recurrent ovarian cancer.
Yang D; Zhang Y; Gong P; Liu F; Gan Y; Bai W
J Obstet Gynaecol Res; 2023 Jul; 49(7):1795-1804. PubMed ID: 37231941
[TBL] [Abstract] [Full Text] [Related]
6. Lymphocyte-activation gene 3 protein expression in tumor-infiltrating lymphocytes is associated with a poor prognosis of ovarian clear cell carcinoma.
Zaitsu S; Yano M; Adachi S; Miwa M; Katoh T; Kawano Y; Yasuda M
J Ovarian Res; 2023 May; 16(1):93. PubMed ID: 37179337
[TBL] [Abstract] [Full Text] [Related]
7. Bruton's Tyrosine Kinase Inhibitors (BTKIs): Review of Preclinical Studies and Evaluation of Clinical Trials.
Rozkiewicz D; Hermanowicz JM; Kwiatkowska I; Krupa A; Pawlak D
Molecules; 2023 Mar; 28(5):. PubMed ID: 36903645
[TBL] [Abstract] [Full Text] [Related]
8. Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma.
Shirai R; Osumi T; Keino D; Nakabayashi K; Uchiyama T; Sekiguchi M; Hiwatari M; Yoshida M; Yoshida K; Yamada Y; Tomizawa D; Takae S; Kiyokawa N; Matsumoto K; Yoshioka T; Hata K; Hori T; Suzuki N; Kato M
Int J Hematol; 2023 Jun; 117(6):910-918. PubMed ID: 36867356
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations.
Yao H; Li N; Yuan H
BMC Cancer; 2022 Dec; 22(1):1337. PubMed ID: 36544182
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/bcr clonal expansion in a relapsed ovarian cancer patient.
Ren Y; Li R; Feng H; Xie J; Gao L; Chu S; Li Y; Meng F; Ning Y
Front Immunol; 2022; 13():985187. PubMed ID: 36248860
[TBL] [Abstract] [Full Text] [Related]
11. Survival benefits of retroperitoneal lymphadenectomy for optimally-resected advanced ovarian high-grade serous carcinoma: a multi-institutional retrospective study.
Ikeda Y; Yoshihara M; Tamauchi S; Yokoi A; Yoshikawa N; Kajiyama H
J Gynecol Oncol; 2022 Jul; 33(4):e40. PubMed ID: 35320889
[TBL] [Abstract] [Full Text] [Related]
12. Gemtuzumab-ozogamicin and blinatumomab as treatment for refractory mixed-phenotype blast crisis in chronic myeloid leukaemia.
Ovilla-Martinez R; Weber Sánchez LA; Cota-Rangel X; Baez-Islas PE
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34764108
[TBL] [Abstract] [Full Text] [Related]
13. Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysis.
Goldberg RM; Kim SR; Fazelzad R; Li X; Brown TJ; May T
Gynecol Oncol; 2022 Jan; 164(1):212-220. PubMed ID: 34756470
[TBL] [Abstract] [Full Text] [Related]
14. Fertility preservation in breast cancer with oral progestin: is it an option? A pilot study.
Oliveira R; Maya BG; Nogueira MBS; Conceição GS; Bianco B; Barbosa CP
Einstein (Sao Paulo); 2021; 19():eAO5859. PubMed ID: 34431852
[TBL] [Abstract] [Full Text] [Related]
15. Disease-inducing potential of two leukemic cell lines in a xenografting model.
Manavella DD; Herraiz S; Soares M; Buigues A; Pellicer A; Donnez J; Díaz-García C; Dolmans MM
J Assist Reprod Genet; 2021 Jun; 38(6):1589-1600. PubMed ID: 33786735
[TBL] [Abstract] [Full Text] [Related]
16. Phase II consolidation trial with anti-Lewis-Y monoclonal antibody (hu3S193) in platinum-sensitive ovarian cancer after a second remission.
Smaletz O; Ismael G; Del Pilar Estevez-Diz M; Nascimento ILO; de Morais ALG; Cunha-Junior GF; Azevedo SJ; Alves VA; Moro AM; Yeda FP; Dos Santos ML; Majumder I; Hoffman EW
Int J Gynecol Cancer; 2021 Apr; 31(4):562-568. PubMed ID: 33664128
[TBL] [Abstract] [Full Text] [Related]
17. Female reproductive function after treatment of childhood acute lymphoblastic leukemia.
Roshandel R; van Dijk M; Overbeek A; Kaspers G; Lambalk C; Beerendonk C; Bresters D; van der Heiden-van der Loo M; van den Heuvel-Eibrink M; Kremer L; Loonen J; van der Pal H; Ronckers C; Tissing W; Versluys B; van Leeuwen F; van den Berg M; van Dulmen-den Broeder E;
Pediatr Blood Cancer; 2021 Apr; 68(4):e28894. PubMed ID: 33459500
[TBL] [Abstract] [Full Text] [Related]
18. Characterization of therapy-related acute leukemia in hereditary breast-ovarian carcinoma patients: role of BRCA1 mutation and topoisomerase II-directed therapy.
Bagal B; Kumar R; Gaur T; Talreja V; Bonda A; Patkar N; Shetty D; Kowtal P; Subramanian PG; Gupta S; Sarin R; Hasan SK
Med Oncol; 2020 Apr; 37(5):48. PubMed ID: 32277283
[TBL] [Abstract] [Full Text] [Related]
19.
Vitale SR; Groenendijk FH; van Marion R; Beaufort CM; Helmijr JC; Dubbink HJ; Dinjens WNM; Ewing-Graham PC; Smolders R; van Doorn HC; Boere IA; Berns EMJJ; Helleman J; Jansen MPHM
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32156073
[TBL] [Abstract] [Full Text] [Related]
20. Comparison of CA 125 alone and risk of ovarian malignancy algorithm (ROMA) in patients with adnexal mass: A multicenter study.
Choi HJ; Lee YY; Sohn I; Kim YM; Kim JW; Kang S; Kim BG
Curr Probl Cancer; 2020 Apr; 44(2):100508. PubMed ID: 31708114
[TBL] [Abstract] [Full Text] [Related]
[Next]